top of page
Search

Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients

Writer's picture: Rita LRita L

Immunotherapy with immune checkpoint inhibitors for non-small cell lung cancer (NSCLC) has emerged as an important treatment option. Although immunotherapy may significantly improve survival and quality of life, response rates are as low as 20% in NSCLC patients.





4 views0 comments

Recent Posts

See All

Комментарии


© 2020 Konnet (Asia) Ltd. All Rights Reserved.

bottom of page